News

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Ono Pharmaceutical Co., Ltd. (OTCMKTS: OPHLY) today announced an ...
Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea
Vertex Pharmaceuticals (Nasdaq: NASDAQ:VRTX) and Ono Pharmaceutical (OTCMKTS: OTCPK:OPHLY) have announced an exclusive ...
Medical Dialogues4d
Atacicept Significantly Reduces Proteinuria in IgA Nephropathy: Phase 3 Trial Results
Researchers have found in phase 3 ORIGIN 3 trial that investigational dual BAFF/APRIL inhibitor atacicept significantly ...